223 related articles for article (PubMed ID: 29382761)
1. Plasticity of
Vilchèze C; Weinrick B; Leung LW; Jacobs WR
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1599-1604. PubMed ID: 29382761
[TBL] [Abstract][Full Text] [Related]
2. Roles of the two type II NADH dehydrogenases in the survival of Mycobacterium tuberculosis in vitro.
Awasthy D; Ambady A; Narayana A; Morayya S; Sharma U
Gene; 2014 Oct; 550(1):110-6. PubMed ID: 25128581
[TBL] [Abstract][Full Text] [Related]
3. Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.
Sellamuthu S; Singh M; Kumar A; Singh SK
Expert Opin Ther Targets; 2017 Jun; 21(6):559-570. PubMed ID: 28472892
[TBL] [Abstract][Full Text] [Related]
4. Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity.
Harbut MB; Yang B; Liu R; Yano T; Vilchèze C; Cheng B; Lockner J; Guo H; Yu C; Franzblau SG; Petrassi HM; Jacobs WR; Rubin H; Chatterjee AK; Wang F
Angew Chem Int Ed Engl; 2018 Mar; 57(13):3478-3482. PubMed ID: 29388301
[TBL] [Abstract][Full Text] [Related]
5. Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development.
Beites T; O'Brien K; Tiwari D; Engelhart CA; Walters S; Andrews J; Yang HJ; Sutphen ML; Weiner DM; Dayao EK; Zimmerman M; Prideaux B; Desai PV; Masquelin T; Via LE; Dartois V; Boshoff HI; Barry CE; Ehrt S; Schnappinger D
Nat Commun; 2019 Oct; 10(1):4970. PubMed ID: 31672993
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. 2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization.
Murugesan D; Ray PC; Bayliss T; Prosser GA; Harrison JR; Green K; Soares de Melo C; Feng TS; Street LJ; Chibale K; Warner DF; Mizrahi V; Epemolu O; Scullion P; Ellis L; Riley J; Shishikura Y; Ferguson L; Osuna-Cabello M; Read KD; Green SR; Lamprecht DA; Finin PM; Steyn AJC; Ioerger TR; Sacchettini J; Rhee KY; Arora K; Barry CE; Wyatt PG; Boshoff HIM
ACS Infect Dis; 2018 Jun; 4(6):954-969. PubMed ID: 29522317
[TBL] [Abstract][Full Text] [Related]
8. Activation of type II NADH dehydrogenase by quinolinequinones mediates antitubercular cell death.
Heikal A; Hards K; Cheung CY; Menorca A; Timmer MS; Stocker BL; Cook GM
J Antimicrob Chemother; 2016 Oct; 71(10):2840-7. PubMed ID: 27365187
[TBL] [Abstract][Full Text] [Related]
9. Type 2 NADH Dehydrogenase Is the Only Point of Entry for Electrons into the Streptococcus agalactiae Respiratory Chain and Is a Potential Drug Target.
Lencina AM; Franza T; Sullivan MJ; Ulett GC; Ipe DS; Gaudu P; Gennis RB; Schurig-Briccio LA
mBio; 2018 Jul; 9(4):. PubMed ID: 29970468
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lethality of
Xu Y; Ehrt S; Schnappinger D; Beites T
bioRxiv; 2023 Apr; ():. PubMed ID: 37090679
[TBL] [Abstract][Full Text] [Related]
11. Imaging the NADH:NAD
Bhat SA; Iqbal IK; Kumar A
Front Cell Infect Microbiol; 2016; 6():145. PubMed ID: 27878107
[TBL] [Abstract][Full Text] [Related]
12. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
[TBL] [Abstract][Full Text] [Related]
13. The Orphan Response Regulator Rv3143 Modulates the Activity of the NADH Dehydrogenase Complex (Nuo) in
Płocińska R; Wasik K; Płociński P; Lechowicz E; Antczak M; Błaszczyk E; Dziadek B; Słomka M; Rumijowska-Galewicz A; Dziadek J
Front Cell Infect Microbiol; 2022; 12():909507. PubMed ID: 35837472
[TBL] [Abstract][Full Text] [Related]
14. CD82 hypomethylation is essential for tuberculosis pathogenesis via regulation of RUNX1-Rab5/22.
Koh HJ; Kim YR; Kim JS; Yun JS; Kim S; Kim SY; Jang K; Yang CS
Exp Mol Med; 2018 May; 50(5):1-15. PubMed ID: 29760437
[TBL] [Abstract][Full Text] [Related]
15. Synthetic lethality of
Xu Y; Ehrt S; Schnappinger D; Beites T
mBio; 2023 Nov; 14(6):e0104523. PubMed ID: 38032200
[TBL] [Abstract][Full Text] [Related]
16. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells.
Velmurugan K; Chen B; Miller JL; Azogue S; Gurses S; Hsu T; Glickman M; Jacobs WR; Porcelli SA; Briken V
PLoS Pathog; 2007 Jul; 3(7):e110. PubMed ID: 17658950
[TBL] [Abstract][Full Text] [Related]
18. Effect of NADH dehydrogenase-disruption and over-expression on respiration-related metabolism in Corynebacterium glutamicum KY9714.
Nantapong N; Kugimiya Y; Toyama H; Adachi O; Matsushita K
Appl Microbiol Biotechnol; 2004 Dec; 66(2):187-93. PubMed ID: 15558275
[TBL] [Abstract][Full Text] [Related]
19. Impact of
Camassa S; Palucci I; Iantomasi R; Cubeddu T; Minerva M; De Maio F; Jouny S; Petruccioli E; Goletti D; Ria F; Sali M; Sanguinetti M; Manganelli R; Rocca S; Brodin P; Delogu G
Front Cell Infect Microbiol; 2017; 7():137. PubMed ID: 28484686
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
Lee AS; Teo AS; Wong SY
Antimicrob Agents Chemother; 2001 Jul; 45(7):2157-9. PubMed ID: 11408244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
